Sibylla has developed a patent-based software platform to apply innovative algorithms and drug design protocols derived from advanced mathematical methods of theoretical physics. Sibylla’s platform enables to reveal with atomic resolution the folding and misfolding mechanisms of bio-medically relevant proteins, thereby unveiling an entirely new class of pharmacological targets.